"The Group is pleased to report that trading for the first half of the current financial year has been ahead of our COVID-19-revised ("C-19") management forecasts. There has been month-on-month improvement in operating profit and cash since the start of the financial year with September moving into profit.
Whilst the C-19 situation remains difficult to predict, the Group is in a robust financial and operating position to navigate FY2021 and continue the solid momentum that was building prior to C-19 and deliver on the exciting growth opportunities that we see ahead of us.
James Dickson, Chairman of Vianet, commented:
"Having seen a month-on-month improvement in operating profit and cash since the start of the financial year, Vianet remains in good shape to come through the C-19 crisis and emerge strongly.
"However, we once again find ourselves in uncharted waters alongside our hospitality sector customers following the government's announcement of further new measures over the past two weeks."
Sounds good in general, and promising for the long term, but vulnerable to the 2nd wave.
Names please DD77.....
PS. The list of institutional shareholders has some pretty good names IMV.
I can't see that. (Which means it probably will!)
So stupid, I can't actually remember why I bought here, and was looking today at selling. But the directors tend to be active in buying and selling, sold at 98p, and recently bought in again. After the results in September, when they were allowed, so not long back. This was the CEO and the FD: big fish, in this small pond.
Other plus points are the Quality rating on Stockopedia (I'm not great at analysis for myself), and it's very cheap, with a good divi.
I'm holding, but somewhat unhappily.
If it's big in the non-profit sector others in that sector with less budget to research may follow along.
They must have been negotiating this contract in September, so it may be why - or part of why - they had such high hopes for October. More to come?? It's great that it's FDA cleared as well as CE marked.
PS Libero, why do you see it as undervalued? I can't do that kind of stuff for tuppence, so I pay for Stockopedia, which rates it as quite expensive. But I'm not so bothered by that as by the quality and momentum factors, for which it gets high ratings on both. [They rate companies by Quality, Value and Momentum measures, making a combined rating of those 3 scores. But from what I can see, over the longest term they can give, Quality and Momentum alone give a slightly better performance.]
2nd October: "...trading in October is expected to suggest a strong Q4 performance..."
Interesting phraseology that: literally they are projecting good October trading, from which they further project a good Q4! But with an extra update being, um, projected in early November - just one month on - it looks like they are expecting great things of October.
Which looks like now is a great time to be in. With the vaccine date being pushed out and further out and this 2nd wave being far more serious than governments expected (otherwise they would have held the lockdown for a further couple of weeks in the summer to knock it right down) I suspect the researchers are getting what they ask for - which means virus samples, and EKF, among other things.
Any thoughts?
bhargav, you've kept the faith for a long, long time, given that it appears to be your only holding. Impressive!
I hope for you - as well as myself! - that it goes very, very well here. And thanks for your continued input, you know this share as well as anyone.
You were right. CFO gone, CEO gone, auditors gone, cash hole by the look of it, my money gone, and the previous auditors confirm there was nothing shareholders needed to be aware of. Really???
I like that last sentence:
“ For those investors who feel they might have missed the boat a little on the surge in the gold miners, this is a perfect and relatively safe way to gain leverage to the gold price as well as a well-executed organic expansion strategy.”
There will be many who are thinking that, or at least “I should have got in earlier”. The share price being down year-on-year is a simple clear point. We all know what’s happened to the price of gold.
Simon Thomson recommendation again today, and Pelatro. Pelatro up 16%, BVC just 3.5. I've seen people diss ST, but my profits from him - including here - have paid for the mag many times over. Just don't follow the other guys! Pardon me, Chris Dillow is useful, John Rosier, and John Baron if you're into investment trusts. It's the main mag tips that have been disastrous in my experience.
10,000 tests a month equates to 333 a day.
Useful within the hospital context no doubt - especially if your machine is sat there idling doing nothing else. Which it won't be. But the automation side WILL be really useful.
I'm in here, but that figure doesn't get my juices going too much.
VERY sophisicated! But that is the high barrier to entry you mentioned, which is good for us. The problem is the time it will still take to develop. ST says:
"Kromek has already developed a prototype to sample air and identify the presence of any biological pathogen – including Covid-19 or any mutant version that may emerge over time. The technology can be used to immediately flag the presence of someone with a contagious disease and allow effective mitigation of the risk of transmission."
Depending on how good this tech really is the end uses could be enormous. ST says, "Importantly, it’s incredibly accurate, giving a false alarm in just one in 800,000 tests."
I don't think they would claim as much as they seem to without real reasons: military minds have to be decisive and they will just lose the contract if they claim without substance. And they have been dealing with the US DoD certainly since ST first recommendation in Feb 2017 - customers you don't want to lose. At that point he said: "..... this is an exciting business segment to be operating in right now given the geopolitical backdrop. That's because the company's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials such as explosives, and the analysis of radioactive materials. The business model provides a vertically-integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application-specific integrated circuits."
Could it be their time has come?
I'm embarrassed (and slightly nervous) to say I bought in here near the top yesterday, at around 1530 @ 13.8: so that's what it was then.
Embarrassed because it's at the top of an 18% rise on the day: not what you normally like to do. Definite case of FOMO. Setting up for a fall on Monday, but then if it goes on up you've missed the boat. That's my highly technical analysis! I do find ST worth following selectively, he's been banging the drum for KMK since early 2017 starting at 25p, and he's not given up it, which is unusual when a share of his is a loser. I nearly bought thanks to him before, and now it's well down, with an accounting bonus to come plus this possible head banger of a machine. Could blow the doors off. Risk/reward looks better than for quite a while.
Wow, Trek, you timed that nicely!
4D has 6 clinical trials going on.
On yesterdays's results of just one of them over 1/3 of the company value was written off, ie you could the total value of the Blautix trial, PLUS ONE OTHER?!
But Blautix is definitively not out of the game, not at all.
And how can you say it writes off the value of one of the other trials as well? Trades and charts are not my game, but this looks like good long term value now. I don't know the system at all, but I do wonder if over the next few days we start getting the RNSs saying that this and that institution has gone over 3%? It's played into their hands. They play the long game - like China.
Ha! I wish I was worthy of that mention, but I am NO EXPERT!!
I think it was Ronald Reagan who said something like "I pick good people, and let them do their job." He did OK.
On most boards of any share worth investing in there are people who know what they are talking about (and it's important to me that they are decent enough to stay out of the mud slinging). I could study my brains out for years and know nothing like what some people on these boards know: however hard I try. The important thing is to find them and then take seriously what they say. I don't follow slavishly, it's my money, my responsibility, and I draw in other sources and make my own choices. I won't make what they make, but still I've been pointed to some good shares. Sometimes people are really knowledgeable only on one share - or area - while others it is well worth looking to see what else they are investing in. It's a great help if they are willing to say when and why they sell! That's harder than the buying decision. Taking profits is sometimes the obvious thing to do, but I find coming out of a share completely a very difficult decision.
My own experience is merely a long forgotten science degree (biological), no relevant work experience, just a few years investing in individual shares, and many years in the markets with funds and trusts. Tbh I would probably do better just to invest in them, but I don't just invest to make money, it is great to know all of what I am in, and why. It's nice to dream of helping the world be a better place. :)
Atb.
Tbh anyone who managed to sell early yesterday was sensible - they now have the opportunity to buy more shares for the same money.
I can't judge short term movements at all. It could drop to 60, no idea, so what unless you sell?
But Blautix is defo still in the game, and I do believe this a good price for the long term. I don't have the skills to quantify that: like science, it's all probabilities - not facts. But the potential is vast both in IBS and elsewhere.